Cwm LLC Grows Holdings in Evolent Health Inc (EVH)

Cwm LLC boosted its position in shares of Evolent Health Inc (NYSE:EVH) by 102.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 147,322 shares of the technology company’s stock after purchasing an additional 74,690 shares during the period. Cwm LLC owned about 0.19% of Evolent Health worth $1,812,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. ETF Managers Group LLC bought a new position in Evolent Health during the 2nd quarter worth about $102,000. BNP Paribas Arbitrage SA increased its holdings in Evolent Health by 815.4% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 4,751 shares of the technology company’s stock worth $120,000 after purchasing an additional 4,232 shares in the last quarter. Legal & General Group Plc increased its holdings in Evolent Health by 122.4% during the 2nd quarter. Legal & General Group Plc now owns 9,846 shares of the technology company’s stock worth $250,000 after purchasing an additional 5,418 shares in the last quarter. Grandeur Peak Global Advisors LLC increased its holdings in Evolent Health by 58.6% during the 3rd quarter. Grandeur Peak Global Advisors LLC now owns 19,625 shares of the technology company’s stock worth $349,000 after purchasing an additional 7,250 shares in the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in Evolent Health by 245.2% during the 2nd quarter. PNC Financial Services Group Inc. now owns 10,357 shares of the technology company’s stock worth $262,000 after purchasing an additional 7,357 shares in the last quarter. Hedge funds and other institutional investors own 95.38% of the company’s stock.

Evolent Health Inc (EVH) opened at $13.80 on Friday. Evolent Health Inc has a one year low of $10.30 and a one year high of $27.50. The company has a debt-to-equity ratio of 0.11, a quick ratio of 3.34 and a current ratio of 3.34. The company has a market cap of $1,070.00 and a PE ratio of -12.11.

Evolent Health (NYSE:EVH) last posted its quarterly earnings data on Thursday, November 2nd. The technology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.04. Evolent Health had a negative net margin of 15.86% and a negative return on equity of 5.05%. The company had revenue of $107.90 million during the quarter, compared to the consensus estimate of $104.49 million. During the same period in the prior year, the business posted ($0.26) EPS. The company’s quarterly revenue was up 79.2% on a year-over-year basis. research analysts anticipate that Evolent Health Inc will post -0.57 earnings per share for the current year.

A number of equities analysts have issued reports on EVH shares. Robert W. Baird reiterated an “outperform” rating and set a $25.00 target price (down previously from $35.00) on shares of Evolent Health in a report on Tuesday, September 26th. They noted that the move was a valuation call. Zacks Investment Research cut Evolent Health from a “hold” rating to a “sell” rating in a report on Monday, October 2nd. Cowen reiterated an “outperform” rating and set a $29.00 target price (down previously from $33.00) on shares of Evolent Health in a report on Friday, October 6th. Canaccord Genuity reiterated a “buy” rating and set a $32.00 target price on shares of Evolent Health in a report on Friday, October 6th. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $30.00 target price on shares of Evolent Health in a report on Thursday, November 2nd. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and thirteen have issued a buy rating to the stock. Evolent Health currently has an average rating of “Buy” and a consensus price target of $28.00.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://stocknewstimes.com/2018/01/19/cwm-llc-grows-holdings-in-evolent-health-inc-evh.html.

Evolent Health Profile

Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.

Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health Inc (NYSE:EVH).

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply